Last reviewed · How we verify

NCT03618433

KİNECT® - Video Games Based Physiotherapy Programme in Patients With Breast Cancer Surgery

Completed NA Last updated 14 November 2019
What this trial tests

NA trial testing study group in Breast Cancer in 34 participants. Completed in 5 August 2019.

Timeline
3 September 2018
Primary endpoint
1 August 2019
5 August 2019

Quick facts

Lead sponsorAcibadem University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment34
Start date3 September 2018
Primary completion1 August 2019
Estimated completion5 August 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Acibadem University

Who can join

Adults 18 to 55, female only, with Breast Cancer or Upper Extremity Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of the study is to investigate the effects of Kinect® video based technology on pain, functionality, muscle strength, fatigue and quality of life in patients with breast cancer surgery and axillary node dissection.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Is Xbox 360 Kinect-based virtual reality training as effective as standard physiotherapy in patients undergoing breast cancer surgery?
    Feyzioğlu Ö, Dinçer S, Akan A, Algun ZC. · · 2020 · cited 71× · PMID 31907649 · DOI 10.1007/s00520-019-05287-x

Verify or expand the search:

Other trials of study group

Trials testing the same drug.

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

Other Acibadem University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03618433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing